Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody

BACKGROUND AND PURPOSE: Despite the widespread utilization of cancer vaccines with specified antigens, the use of whole tumor cell lysates in tumor immunotherapy would be a very promising approach that can overcome several significant obstacles in vaccine production. Whole tumor cells provide a broa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimmanesh, Ilnaz, Esmaili, Yasaman, Ghafouri, Elham, Hejazi, Seyed Hossein, Khanahmad, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976059/
https://www.ncbi.nlm.nih.gov/pubmed/36873278
http://dx.doi.org/10.4103/1735-5362.367793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976059/
https://www.ncbi.nlm.nih.gov/pubmed/36873278
http://dx.doi.org/10.4103/1735-5362.367793

Ejemplares similares